As of 2:30 PM on the 13th, Access Bio is trading at 3,790 KRW, up 1.34% from the previous day. This represents a 21.47% increase compared to July 8. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.
Over the past five days, individual investors have net purchased 407,593 shares, while foreigners and institutions have net sold 414,353 shares and net purchased 4,520 shares, respectively.
On July 9, Access Bio became a market issue with the announcement of "COVID-19 diagnostic kit approved for use in the US (comprehensive)."
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
